Pfizer unexpectedly announced Friday that it had scrapped its bid to have its COVID-19 vaccine approved for children ages 6 months to 5 years old.
The pharmaceutical giant and its partner, BioNTech, at the beginning of the month had applied for emergency use authorization with the Food and Drug Administration based on a quicker timeline of research on just two shots.
But the companies announced Friday that they were going to “extend their rolling submission” to the FDA to await fuller testing on three-shot doses.
Load More
Yorumlar
Kalan Karakter: